Trials / Completed
CompletedNCT07092397
Artificial Intelligence-based Tumor Microenvironment Analysis for Prognosis Prediction in Gallbladder Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 266 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This retrospective study aims to investigate the prognostic significance of artificial intelligence (AI)-powered analysis of tumor-infiltrating lymphocytes (TILs) and the tumor microenvironment (TME) in patients with resected gallbladder cancer. Using hematoxylin and eosin (H\&E)-stained slides, the study quantifies spatial TME features, including TIL density, tertiary lymphoid structures, and fibroblast density, to identify potential TME-related risk factors associated with survival.
Conditions
Timeline
- Start date
- 2022-04-05
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2025-07-29
- Last updated
- 2025-07-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07092397. Inclusion in this directory is not an endorsement.